RxRevu has filed a notice of an exempt offering of securities to raise $10,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, RxRevu is raising $10,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kyle Kiser played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About RxRevu
Arrive Health (formerly RxRevu) is a healthcare technology company dedicated to putting the needs of patients and providers first. We improve access to the most affordable, quality care by delivering accurate, patient-specific cost and coverage data to providers, care teams, and patients. Collaborating with premier health systems, pharmacy benefit managers, payers, and healthcare IT vendors, Arrive Health is clearing the way for better health by reducing friction in care workflows and enabling meaningful conversations about access to care.
To learn more about RxRevu, visit http://rxrevu.com/
Contact:
Kyle Kiser, Chief Executive Officer
800-360-4965
https://www.linkedin.com/in/kyle-kiser-68ba218/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.